Cargando…
IMPACT-CABG Trial: Implantation of CD133(+) Stem Cells in Patients Undergoing Coronary Bypass Surgery—Presentation of the First Treated Patient
The IMPACT-CABG study is the first Canadian randomized-controlled phase II clinical trial aiming to assess the effect of intramyocardial (IM) injections of CD133(+)-selected stem cells in patients referred for coronary artery bypass graft (CABG) with a “chronic” myocardial infarction and persistent...
Autores principales: | Forcillo, Jessica, Stevens, Louis-Mathieu, Mansour, Samer, Prieto, Ignacio, Roy, Denis-Claude, Noiseux, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505958/ https://www.ncbi.nlm.nih.gov/pubmed/23213603 http://dx.doi.org/10.1155/2011/685394 |
Ejemplares similares
-
A rare case of anomalous origin of the left main coronary artery in an adult patient
por: Dionne, Pierre O, et al.
Publicado: (2013) -
One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133(+) Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction
por: Mansour, Samer, et al.
Publicado: (2011) -
Composite versus conventional coronary artery bypass grafting strategy for the anterolateral territory: study protocol for a randomized controlled trial
por: Drouin, Ariane, et al.
Publicado: (2013) -
A pilot study on development and feasibility of the ‘MyEducation: CABG application’ for patients undergoing coronary artery bypass graft (CABG) surgery
por: Noor Hanita, Z., et al.
Publicado: (2022) -
Impact of early quantitative morbidity on 1-year outcomes in coronary artery bypass graft surgery
por: Hébert, Mélanie, et al.
Publicado: (2021)